IL15 and pancreatic neoplasm: The same group subsequently reported that the levels of interlukein (IL)-8 and IL-15 were positively associated with the OS of pancreatic cancer patients, and served as potential predictive biomarkers for the therapeutic effect of combined OT-101 and chemotherapy administration for pancreatic cancer [25].